P Lesavre

Author PubWeight™ 71.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998 4.31
2 A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997 3.62
3 Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000 3.60
4 The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods 1993 1.86
5 Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients. J Rheumatol 1993 1.86
6 Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 1993 1.56
7 H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int 1986 1.55
8 Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med 1993 1.48
9 Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 2006 1.37
10 Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985 1.34
11 A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 1999 1.34
12 European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus 2009 1.28
13 Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett 1995 1.26
14 Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme. J Clin Invest 1980 1.25
15 Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood 1999 1.23
16 Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992 1.21
17 Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 1982 1.19
18 Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 1993 1.17
19 Renal vascular lesions in lupus nephritis. Medicine (Baltimore) 1997 1.14
20 Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis. Clin Immunol Immunopathol 1988 1.10
21 Human neutrophils release their major membrane sialoprotein, leukosialin (CD43), during cell activation. Eur J Immunol 1992 1.09
22 Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods 1996 1.08
23 Education of human lymphocytes against mouse cells: specific recognition of H-2 antigens. Eur J Immunol 1977 1.05
24 A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum. J Immunol Methods 1982 1.02
25 Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol 1982 1.02
26 Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study. Rheumatology (Oxford) 2001 1.00
27 Antineutrophil cytoplasmic antibodies in IgA nephropathy and Henoch-Schönlein purpura. Nephrol Dial Transplant 1992 0.96
28 Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 1982 0.93
29 Evidence for integrins other than beta 2 on polymorphonuclear neutrophils: expression of alpha 6 beta 1 heterodimer. J Leukoc Biol 1993 0.93
30 Isotype and affinity of anti-myeloperoxidase autoantibodies in systemic vasculitis. Kidney Int 1994 0.93
31 Characterization of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti-neutrophil cytoplasmic autoantibodies. FEBS Lett 1996 0.92
32 Multiple opportunistic infection due to AIDS in a previously healthy black woman from Zaire. N Engl J Med 1983 0.92
33 Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheumatol 1995 0.90
34 Distribution of integrin subunits in normal human kidney. Cell Adhes Commun 1994 0.90
35 Serum IgA preferentially binds to cationic polypeptides in IgA nephropathy. Clin Exp Immunol 1988 0.89
36 Early membrane events in polymorphonuclear cell (PMN) apoptosis: membrane blebbing and vesicle release, CD43 and CD16 down-regulation and phosphatidylserine externalization. Biochem Soc Trans 2004 0.89
37 Alternative pathway of complement activation by human lymphoblastoid B and T cell lines. J Immunol 1983 0.89
38 Glomerular and serum immunoglobulin G subclasses in IgA nephropathy. Clin Immunol Immunopathol 1989 0.88
39 Induction of Fc receptors for IgA on murine T cell hybridoma by human monoclonal IgA and by high molecular weight IgA in IgA nephropathy. Clin Exp Immunol 1987 0.87
40 Leukosialin (CD43, sialophorin) redistribution in uropods of polarized neutrophils is induced by CD43 cross-linking by antibodies, by colchicine or by chemotactic peptides. J Cell Sci 1997 0.86
41 Differential regulation of tumor necrosis factor-alpha-converting enzyme and angiotensin-converting enzyme by type I and II interferons in human normal and leukemic myeloid cells. Oncogene 2006 0.86
42 Proteinase 3. A neutrophil proteinase with activity on platelets. J Immunol 1994 0.85
43 Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody. Clin Exp Immunol 1982 0.85
44 CD43 (sialophorin, leukosialin) shedding is an initial event during neutrophil migration, which could be closely related to the spreading of adherent cells. Cell Adhes Commun 1998 0.83
45 Nonneoplastic circulating Sézary-like cells in cutaneous T-cell lymphoma. Ultrastructural, immunologic, and T-cell receptor gene-rearrangement studies. Cancer 1987 0.82
46 Pulmonary giant bulla in Wegener's granulomatosis. Scand J Rheumatol 2000 0.81
47 Complement alternative pathway activation by chronic lymphocytic leukemia cells: its role in their hepatosplenic localization. Blood 1984 0.81
48 [Value of plasma exchange in necrotizing angeitis. 11 cases]. Nouv Presse Med 1982 0.80
49 Effects of cyclosporine in severe systemic lupus erythematosus. J Pediatr 1987 0.80
50 Distribution of alphavbeta3, alphavbeta5 integrins and the integrin associated protein--IAP (CD47) in human glomerular diseases. Cell Adhes Commun 2000 0.79
51 POEMS syndrome presenting as systemic sclerosis. Clinical and pathologic study of a case with microangiopathic glomerular lesions. Am J Med 1988 0.79
52 Glomerular involvement in lymphoproliferative disorders with hyperproduction of cytokines (Castleman, POEMS). Adv Nephrol Necker Hosp 2000 0.78
53 C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study. Clin Exp Immunol 1988 0.78
54 Adhesion molecules in human crescentic glomerulonephritis. J Pathol 1996 0.78
55 A case of amicrobial pustulosis of the folds associated with neutrophilic gastrointestinal involvement in systemic lupus erythematosus. Dermatology 2005 0.78
56 Role of alpha v integrins in mesangial cell adhesion to vitronectin and von Willebrand factor. Kidney Int 1997 0.77
57 Haemophilus parainfluenzae meningitis in an adult with an inherited deficiency of the seventh component of complement. Arch Intern Med 1987 0.77
58 [Problems posed by pregnancy in women with lupus nephropathy]. Presse Med 1983 0.77
59 Characteristics of eluted IgA in primary IgA nephropathy. Contrib Nephrol 1984 0.76
60 Neutrophil serine proteases are most probably involved in the release of CD43 (leukosialin, sialophorin) from the neutrophil membrane during cell activation. Blood 1996 0.76
61 Inhibition of alternative pathway factor D by factor B-related synthetic hexapeptides. Eur J Immunol 1982 0.76
62 [Association of thymoma, superficial pemphigus, nephrotic syndrome and lupus biology]. Ann Dermatol Venereol 1981 0.76
63 Idiopathic focal segmental glomerulosclerosis--new lessons from kidney transplantation. N Engl J Med 1996 0.75
64 [Therapeutic use of immunostimulants against infections (author's transl)]. Comp Immunol Microbiol Infect Dis 1980 0.75
65 [Subacute septicemia caused by Meningococcus of serogroup Y and acquired deficiency of complement C3 fraction]. Ann Med Interne (Paris) 1986 0.75
66 New RFLPs of the immunoglobulin switch alpha region in mesangial IgA glomerulonephritis. Hum Genet 1991 0.75
67 [Hypocomplementemic urticarial vasculitis with glomerulopathy and renal venulitis]. Nephrologie 1984 0.75
68 Allogeneic lymphocyte-dependent antibodies (LDA). Specificity of Fc receptors. Transplantation 1977 0.75
69 [Immunostimulants]. Rev Prat 1980 0.75
70 [Immunology (I). In practice...one should remember...]. Rev Prat 1980 0.75
71 [Use of corticoids in immunologic diseases]. Rev Prat 1980 0.75
72 Leukopenia and complement activation induced by different dialysis membranes. Contrib Nephrol 1984 0.75
73 ["Idiopathic" extracapillary glomerulonephritides without immune deposits are vascularitides: clinical and serologic analysis]. Bull Acad Natl Med 1993 0.75
74 How frequent are hepatitis B virus markers in adult patients with glomerular diseases in a low endemic country? A French study from Paris and Saint-Brieuc. Nephron 1993 0.75
75 Properties of bispecific rosette-forming cells. III.---Antigen binding cells with double specificity after immunization with two covalently linked antigens. Ann Immunol (Paris) 1976 0.75
76 [Progress in the knowledge of complement. I. Structure, activation and control of the complement system]. Nouv Presse Med 1979 0.75
77 Clinical and molecular diagnosis in inherited kidney diseases: three examples. Contrib Nephrol 1997 0.75
78 Genetic aspects of complement and glomerulonephritis. Adv Nephrol Necker Hosp 1984 0.75
79 Clinical significance of ANCA in 98 patients. Adv Exp Med Biol 1993 0.75
80 [Role of complement C5 fraction in the adult respiratory distress syndrome]. Presse Med 1985 0.75
81 Lupus nephritis: assessing the evidence, considering the future. Lupus 2007 0.75
82 [Acquired hypogammaglobulinemia and systemic granulomatosis]. Ann Med Interne (Paris) 1995 0.75
83 Neutrophil biology in relation to renal diseases. Adv Nephrol Necker Hosp 2001 0.75
84 [Treatment of severe systemic lupus erythematosus. Long-term results in 55 patients (author's transl)]. Nouv Presse Med 1980 0.75
85 [Immunology (II). In practice...one should remember...]. Rev Prat 1980 0.75
86 Granulomatous renal disease in a patient with common variable immunodeficiency. Am J Kidney Dis 2001 0.75
87 Serum IgG subclasses in secondary immunodeficiencies. Monogr Allergy 1988 0.75
88 Determination of anti-neutrophil cytoplasm antibodies (ANCA) specificity by immunofluorescence on chronic myelocytic leukemia cells. J Immunol Methods 1992 0.75
89 Association between acute lymphoblastic leukemia and partial IgA deficiency in a young man--a family study. Nouv Rev Fr Hematol 1990 0.75
90 [Necrotizing extracapillary glomerulonephritis without immunoglobulin deposits. Renal localization of systemic vasculitis with anti-cytoplasm polynuclear antibodies]. Presse Med 1991 0.75
91 Cutaneous pheomorphic T cell lymphoma. Immunologic, virologic, and T-cell receptor gene rearrangement studies in one European case with initial pseudolymphoma presentation. J Am Acad Dermatol 1986 0.75
92 [Kawasaki syndrome in a young adult. Dermatologic and immunologic study]. Sem Hop 1982 0.75
93 [Extracapillary and necrotizing glomerulonephritis without immunoglobulin deposits: clinical and nosological aspects]. Nephrologie 1992 0.75
94 Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy. Nephrol Dial Transplant 1991 0.75
95 [Progress in the knowledge of complement. II. Nephritic factors]. Nouv Presse Med 1979 0.75
96 [Intra-uterine detection of atrio-ventricular block in two children whose mother had Sjögren's syndrome]. Nouv Presse Med 1982 0.75
97 [Hormonal modulation in disseminated lupus erythematosus: the preliminary results with danazol and cyproterone acetate]. Ann Med Interne (Paris) 1986 0.75
98 Ethical aspects in renal transplantation. Kidney Int Suppl 1983 0.75
99 Immune regulation in IgA nephropathy. Nephrologie 1989 0.75
100 General toxicity of water-soluble iodinated contrast media. Pathogenic concepts. Invest Radiol 1988 0.75
101 [Long-term course of 32 cases of diffuse proliferative lupus glomerulonephritis, treated with corticoids alone or combined with cyclophosphamide]. J Urol Nephrol (Paris) 1979 0.75
102 Lack of platelet response to collagen associated with autoantibodies against glycoprotein (GP) Ia/IIa and Ib/IX leading to the discovery of SLE. Hematol Cell Ther 1996 0.75
103 Antimyeloperoxidase antibodies in elderly females with severe antiglomerular basement membrane disease. Nephrol Dial Transplant 1992 0.75
104 Immune-complexes solubilization: effect of antigen-antibody ratio and relative role of alternative and classical complement pathways. Mol Immunol 1983 0.75
105 [Difficulties of therapeutic option in severe forms of systemic lupus erythematosus]. Ann Med Interne (Paris) 1994 0.75
106 [Familial deficiency of complement factor 7: association with bacterial meningitis. Apropos of 3 recent cases]. Pathol Biol (Paris) 1988 0.75
107 [Association of lymphoepithelial thymoma and systemic lupus erythematosus]. Ann Med Interne (Paris) 1985 0.75
108 Genetic factors in IgA nephropathy (Berger's disease). Adv Nephrol Necker Hosp 1992 0.75